Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Invested Capital (2014 - 2023)

Updated

Grace Therapeutics (GRCE) posted Invested Capital of $64.7 million for fiscal Q3 2024 (quarter ended Dec 31, 2023).

Analysis

Grace Therapeutics (GRCE) Invested Capital (2014 - 2023) Analysis & Trends

For FY2023 (ended Mar 31, 2023), Grace Therapeutics' Invested Capital came in at $68.03 million.

  • Annual Invested Capital shows a four-year compound annual growth rate of 53.0% (FY2019 to FY2023).
  • In prior fiscal years, Grace Therapeutics' Invested Capital was $12.41 million in FY2019.
  • The fiscal Q3 2024 figure stands as the lowest quarterly Invested Capital since fiscal Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 89.77 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 126.18 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 76.32 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 98.72 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 46.28 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 68.36 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 39.27 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 151.97 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 64.70 Mn
Mar 31, 2023 68.03 Mn
Mar 31, 2019 11.76 Mn
Jun 30, 2018 5.66 Mn
Aug 31, 2014 32.16 Mn
API Access

Grace Therapeutics Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=GRCE&period=max&api_key=YOUR_API_KEY